BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Soubières AA, Poullis A. Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2016; 7(1): 41-50 [PMID: 26855811 DOI: 10.4292/wjgpt.v7.i1.41]
URL: https://www.wjgnet.com/1007-9327/full/v7/i1/41.htm
Number Citing Articles
1
Fabio Corsi, Luca Sorrentino, Sara Albasini, Francesco Colombo, Maria Cigognini, Alessandro Massari, Carlo Morasso, Serena Mazzucchelli, Francesca Piccotti, Sandro Ardizzone, Gianluca M. Sampietro, Marta Truffi. Circulating Fibroblast Activation Protein as Potential Biomarker in Patients With Inflammatory Bowel DiseaseFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.725726
2
Fadi H. Mourad, Yunki Yau, Valerie C. Wasinger, Rupert W. Leong. Proteomics in Inflammatory Bowel Disease: Approach Using Animal ModelsDigestive Diseases and Sciences 2017; 62(9): 2266 doi: 10.1007/s10620-017-4673-0
3
V A Akhmedov, O V Gaus. Pancreatic diseases and inflammatory bowel diseases: a random or regular combination?Terapevticheskii arkhiv 2020; 92(1): 76 doi: 10.26442/00403660.2020.01.000463
4
Katharina Schönauen, Nha Le, Ulrike von Arnim, Christian Schulz, Peter Malfertheiner, Alexander Link. Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel DiseasesInflammatory Bowel Diseases 2018; 24(7): 1547 doi: 10.1093/ibd/izy046
5
Gursimran Kochhar, Bret Lashner. Utility of Biomarkers in the Management of Inflammatory Bowel DiseaseCurrent Treatment Options in Gastroenterology 2017; 15(1): 105 doi: 10.1007/s11938-017-0129-z
6
Z. Linneman, C. Reis, K. Balaji, J. Moore, S. Braude. The vitamin D positive feedback hypothesis of inflammatory bowel diseasesMedical Hypotheses 2019; 127: 154 doi: 10.1016/j.mehy.2019.04.005
7
NorahMohammed Almarri, AlaaJamal Alobaidli, AhmedAbdullah Almarhabi, MohammedAhmed Alshammari. Acute pancreatitis as an initial presentation of Crohn's disease: A case reportJournal of Family Medicine and Primary Care 2019; 8(11): 3752 doi: 10.4103/jfmpc.jfmpc_753_19
8
Wojciech Marlicz, Karolina Skonieczna-Żydecka, Konstantinos John Dabos, Igor Łoniewski, Anastasios Koulaouzidis. Emerging concepts in non-invasive monitoring of Crohn’s diseaseTherapeutic Advances in Gastroenterology 2018; 11: 175628481876907 doi: 10.1177/1756284818769076
9
Beata Wilenska, Dagmara Tymecka, Marcin Włodarczyk, Aleksandra Sobolewska-Włodarczyk, Maria Wiśniewska-Jarosińska, Jolanta Dyniewicz, Árpád Somogyi, Jakub Fichna, Aleksandra Misicka. Enkephalin degradation in serum of patients with inflammatory bowel diseasesPharmacological Reports 2019; 71(1): 42 doi: 10.1016/j.pharep.2018.08.001
10
Marisa Iborra, Javier Pérez-Gisbert, Marta Maia Bosca-Watts, Alicia López-García, Valle García-Sánchez, Antonio López-Sanromán, Esther Hinojosa, Lucía Márquez, Santiago García-López, María Chaparro, Montserrat Aceituno, Margalida Calafat, Jordi Guardiola, Blanca Belloc, Yolanda Ber, Luis Bujanda, Belén Beltrán, Cristina Rodríguez-Gutiérrez, Jesús Barrio, José Luis Cabriada, Montserrat Rivero, Raquel Camargo, Manuel van Domselaar, Albert Villoria, Hugo Salata Schuterman, David Hervás, Pilar Nos. Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patientsJournal of Gastroenterology 2017; 52(7): 788 doi: 10.1007/s00535-016-1274-1
11
Majken Lindholm, Tina Manon-Jensen, Gunvor Iben Madsen, Aleksander Krag, Morten Asser Karsdal, Jens Kjeldsen, Joachim Høg Mortensen. Extracellular Matrix Fragments of the Basement Membrane and the Interstitial Matrix Are Serological Markers of Intestinal Tissue Remodeling and Disease Activity in Dextran Sulfate Sodium ColitisDigestive Diseases and Sciences 2019; 64(11): 3134 doi: 10.1007/s10620-019-05676-6
12
Koji Yoshino, Takayuki Nakayama, Ayumu Ito, Eiichi Sato, Shigehisa Kitano. Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: potential role of Th1-dominant immune response in immune-related adverse events: two case reportsBMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6138-7
13
Eddie X. Shen, Anton Lord, James D. Doecke, Katherine Hanigan, James Irwin, Richard K.Y. Cheng, Graham Radford-Smith. A validated risk stratification tool for detecting high-risk small bowel Crohn's diseaseAlimentary Pharmacology & Therapeutics 2020; 51(2): 281 doi: 10.1111/apt.15550
14
Uri Netz, Jane Carter, M Robert Eichenberger, Kayla Feagins, Norman J Galbraith, Gerald W Dryden, Jianmin Pan, Shesh N Rai, Susan Galandiuk. Plasma microRNA Profile Differentiates Crohn’s Colitis From Ulcerative ColitisInflammatory Bowel Diseases 2018; 24(1): 159 doi: 10.1093/ibd/izx009
15
Reza Yarani, Aashiq H. Mirza, Simranjeet Kaur, Flemming Pociot. The emerging role of lncRNAs in inflammatory bowel diseaseExperimental & Molecular Medicine 2018; 50(12): 1 doi: 10.1038/s12276-018-0188-9
16
Kei Motooka, Koichi Morishita, Nami Ito, Shinichiro Shinzaki, Taku Tashiro, Satoshi Nojima, Kayoko Shimizu, Mutsuhiro Date, Natsumi Sakata, Momoko Yamada, Shinji Takamatsu, Yoshihiro Kamada, Hideki Iijima, Tsunekazu Mizushima, Eiichi Morii, Tetsuo Takehara, Eiji Miyoshi. Detection of fucosylated haptoglobin using the 10-7G antibody as a biomarker for evaluating endoscopic remission in ulcerative colitisWorld Journal of Gastroenterology 2021; 27(2): 162-175 doi: 10.3748/wjg.v27.i2.162
17
Francesca Palone, Roberta Vitali, Salvatore Cucchiara, Maurizio Mennini, Alessandro Armuzzi, Daniela Pugliese, Renata DʼIncà, Brigida Barberio, Laura Stronati. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic RemissionInflammatory Bowel Diseases 2016; 22(12): 2886 doi: 10.1097/MIB.0000000000000938
18
Bjoern Titz, Raffaella Gadaleta, Giuseppe Lo Sasso, Ashraf Elamin, Kim Ekroos, Nikolai Ivanov, Manuel Peitsch, Julia Hoeng. Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker IdentificationInternational Journal of Molecular Sciences 2018; 19(9): 2775 doi: 10.3390/ijms19092775
19
Rui Zhou, Peishan Qiu, Haizhou Wang, Huijie Yang, Xueying Yang, Mingliang Ye, Fan Wang, Qiu Zhao. Identification of microRNA-16-5p and microRNA-21-5p in feces as potential noninvasive biomarkers for inflammatory bowel diseaseAging 2021; 13(3): 4634 doi: 10.18632/aging.202428
20
Lucille Quénéhervé, Grégoire David, Arnaud Bourreille, Jean Benoît Hardouin, Gabriel Rahmi, Michel Neunlist, Jérémy Brégeon, Emmanuel Coron. Quantitative assessment of mucosal architecture using computer-based analysis of confocal laser endomicroscopy in inflammatory bowel diseasesGastrointestinal Endoscopy 2019; 89(3): 626 doi: 10.1016/j.gie.2018.08.006
21
Daniel Sprockett, Natalie Fischer, Rotem Sigall Boneh, Dan Turner, Jarek Kierkus, Malgorzata Sladek, Johanna C Escher, Eytan Wine, Baruch Yerushalmi, Jorge Amil Dias, Ron Shaoul, Michal Kori, Scott B Snapper, Susan Holmes, Athos Bousvaros, Arie Levine, David A Relman. Treatment-Specific Composition of the Gut Microbiota Is Associated With Disease Remission in a Pediatric Crohn’s Disease CohortInflammatory Bowel Diseases 2019; 25(12): 1927 doi: 10.1093/ibd/izz130
22
Charalampia Amerikanou, Eirini Dimitropoulou, Aristea Gioxari, Efstathia Papada, Anthi Tanaini, Charalambos Fotakis, Panagiotis Zoumpoulakis, Andriana C. Kaliora. Linking the IL-17A immune response with NMR-based faecal metabolic profile in IBD patients treated with MastihaBiomedicine & Pharmacotherapy 2021; 138: 111535 doi: 10.1016/j.biopha.2021.111535
23
Marisa Iborra, Belén Beltrán, Pilar Nos. Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel DiseaseGastrointestinal Endoscopy Clinics of North America 2016; 26(4): 641 doi: 10.1016/j.giec.2016.06.005
24
Iolanda Agliata, Nora Fernandez-Jimenez, Chloe Goldsmith, Julien C. Marie, Jose R. Bilbao, Robert Dante, Hector Hernandez-Vargas. The DNA methylome of inflammatory bowel disease (IBD) reflects intrinsic and extrinsic factors in intestinal mucosal cellsEpigenetics 2020; 15(10): 1068 doi: 10.1080/15592294.2020.1748916
25
Anita Bálint, Barbara Dorottya Lovász. Editorial: Game Changers in Inflammatory Bowel DiseasesFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.795597